Charles Russell Speechlys advises Juno Health pharmacy group on its acquisition of the Avicenna Pharmacy group
Charles Russell Speechlys has advised the Juno Health pharmacy group on its acquisition of the entire issued share capital of Avicenna Holdings Ltd, which comprises of 21 pharmacies, as well as Avicenna’s buying group operations and serving more than 1,000 pharmacies.
The transaction proceeded by way of a scheme of arrangement and achieved final completion on 19 September 2019. With this purchase, Juno Health will further establish its position as one of the largest pharmacy chains in the Northeast of England.
Juno Health Chairman Richard Smith said: “Avicenna is a well-established business delivering clear benefits to its members. It is one of the most recognisable brands among independent pharmacists and extremely well respected.”
Juno Health Chief Commercial Officer said “Many thanks to team at Charles Russell Speechlys, whose commercially astute advice has been instrumental in supporting us to deliver our acquisition strategy over the past few years.”
Client Partner at Charles Russell Speechlys, Tim Jenkins commented: “We were delighted to advise Juno Health on this latest acquisition. This was a complex project and involved specialist input not just from our dedicated Pharmacy Transactions team and Corporate Group but also specialists in our Real Estate, Employment, Pensions, Commercial and Tax teams. We wish the Juno team well as they look ahead to continue building on Avicenna’s success and platform of services to its members.”
The transaction was handled by Charles Russell Speechlys’ dedicated Pharmacy Transactions team working in partnership with the Firm’s corporate group and was led by Juno Health’s Client Partner Tim Jenkins, Corporate Partner Mark Howard, Corporate Senior Associate Charlie Ring and Real Estate Senior Associate Michelle Noble.
Powering Real Estate
Is it plausible to meet the governments ambitious plan to get new houses off the gas grid by 2025? Watch our webinar here
Private companies and public interest – a new approach to corporate governance?
Pandemic Clauses: sharing (risk) is not (necessarily) caring
A County Court decision has refused to include a clause in a renewal lease to reduce the rent by 50% in the event of future lockdowns
Service charge demands: a reminder of key principles
What are the key principles, implications and key takeaways?
Record success for Charles Russell Speechlys’ Private Wealth practice in Chambers HNW 2021 directory
We are delighted to have once again been recognised as a leader in our field in the Chambers High Net Worth 2021 Guide.
Finance Bill 21/22: the implications for corporate taxpayers
The Finance Bill 2021-2022 was published yesterday. What impact will this have on corporate tax payers?
Barclay v Barclay: A Stark Reminder for Badly Behaved High-Profile Litigants
David considers the Barclay v Barclay case and if the judgment should be published, given it's severe criticism of Lord Barclay's conduct
Is now the optimal time to sell your company?
Charles Russell Speechlys advises Duke Royalty on royalty financing agreement with Fairmed Healthcare AG
Duke Royalty is the leading provider of royalty finance to companies in the UK and Europe.
Jennifer Berritt and Lauren Kelly write for P3 Pharmacy on The Lease Code and looking for better lease terms
The Lease Code published by The Royal Institution of Chartered Surveyors took effect on 1 September 2020.
Charles Russell Speechlys shortlisted for Best EIS/SEIS Legal/Regulatory Adviser at 2021 EISA Awards
The Awards denote excellence and recognise the achievements of EIS/SEIS practitioners over the past year.
COVID-19 Vaccination – can an employer make it compulsory for employees?
We review what legal issues to take into account when considering to make vaccination compulsory as an employer.
Charles Russell Speechlys advises on the sale of No.1 Lounges Ltd to SwissportALD
SwissportALD will run nine No.1 Lounge properties at the UK’s London Heathrow, London Gatwick, and Birmingham airports.
Northern Light: Illuminating IR35
Guy and Hugh take a look at the recent case of Northern Light Solutions Ltd v Revenue and Customs Comrs
Charles Russell Speechlys releases H1 2021 deal highlights
Our deal highlights from the past 6 months are now available.
Housing-with-care considered in first ever parliamentary debate
The first ever formal parliamentary debate into housing-with-care focussed on the effect of the Covid-19 pandemic on retirement communities
Noel Wardle wrote for Chemist & Druggist on the implications of the new Health and Care Bill mean for community pharmacy
The government has now published its proposed overhaul of health and care in England.
Q&A: Duval and consent for alterations
Q&A from a landlord and tenant on consent to carry out works in the light of the Supreme Court ruling in Duval.
Dispensation from consultation and major works
The Court of Appeal upheld the FTT judgement in Aster Communities v Chapman & Others, but what does this mean for landlords and tenants?
Property Patter: the whys and wherefores of receivership
What is a fixed charge receiver?